Dorian Readnour | Vice President, International
Sarepta Therapeutics

Dorian Readnour, Vice President, International, Sarepta Therapeutics

Dorian Readnour is a seasoned professional with over 20 years of experience in the healthcare industry, specializing in patient access across both US and global functions. She began her career after earning a master's degree from the University of Pennsylvania and working at the Children's Hospital of Philadelphia. Currently serving as the Vice President of International Business, she oversees a range of critical activities including the development and execution of global market access strategies, managing international partnerships, navigating regulatory landscapes, and ensuring the availability of treatments to patients worldwide. Her extensive expertise and leadership have been instrumental in driving the company's mission to improve patient outcomes on a global scale.

Appearances:



Day 1- World Orphan Drug Congress USA 2025 @ 15:50

Panel: The do's and don'ts of early access programs

Experienced panelists will share their experiences in designing, operating and closing out EAPS, with an in depth look at the success and failures encountered along the way.  To be moderated by an expert EAP Ethicist that can provide additional context and situational learnings from her experience supporting a vast number of small and large pharmaceutical companies running EAPs.

last published: 24/Apr/25 11:35 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 
 

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Kaylee Nguyen
kaylee.nguyen@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com